GlassScriptPhysician profile
Brandon Lebioda
NPI 1386308401
$2,813.76
in general payments reported to CMS, 2019-2025
10 companies · $982 in 2025
The $982 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,334 · 2023: $331 · 2024: $167 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $810 · Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $809.88 |
| Food and Beverage | $670.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $1,200.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $958.37 | 2023-2025 | Iovera, Exparel, Zilretta |
| Miach Orthopaedics, INC. | $191.92 | 2025 | |
| Si-Bone, INC. | $147.59 | 2023 | |
| Stryker Corporation | $133.81 | 2022 | |
| Smith+Nephew, INC. | $95.89 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Ermi LLC | $35.23 | 2024 | |
| Vericel Corporation | $21.65 | 2024 | Maci |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2025 | Wainua |
| Solventum Corporation | $13.93 | 2024 | Prevena, Activ.A.C., 3m Cavilon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Lebioda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.